Driven by OHSU research, FDA approves new drug to prevent hearing loss in children with cancer

Treatment with sodium thiosulfate will improve health outcomes and quality of life for pediatric cancer patients

By Nicole Rideout January 17, 2023 Portland, Oregon

Downloads

Edward Neuwelt, M.D. (OHSU)

Kristy Knight, M.S. (OHSU)

Leslie Muldoon, Ph.D. (OHSU)

New drug to prevent hearing loss in children with cancer

Brielle, a young cancer survivor who received treatment at OHSU, received sodium thiosulfate following several chemotherapy sessions. (Courtesy of Jennifer Boesche)